SELLAS Life Sciences Group (NASDAQ:SLS – Get Free Report) and Imunon (NASDAQ:IMNN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility SELLAS Life Sciences […]
Imunon, Inc. (NASDAQ:IMNN – Free Report) – Stock analysts at Brookline Capital Management lifted their FY2023 EPS estimates for Imunon in a report released on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($2.25) for the year, up from their previous forecast of […]
IMUNON Announces First Patient enrolled in Phase 1/2 Clinical Trial of IMNN-001 in Combination with bevacizumab in Advanced Ovarian Cancer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Imunon (IMNN) Appoints Dr Patrick Ott to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Imunon, Inc. (NASDAQ:IMNN – Get Free Report) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 36,600 shares, a decrease of 33.9% from the August 31st total of 55,400 shares. Based on an average daily volume of 22,500 shares, the days-to-cover ratio is […]